Promontory Therapeutics

New York, United States

Promontory Therapeutics is a clinical-stage pharmaceutical company focused on novel therapeutics in oncology.

$37.0M raised

Dec 2021

Series A

Biotechnology Life Science Oncology Pharmaceutical

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Promontory Therapeutics

How much funding has Promontory Therapeutics raised?

Promontory Therapeutics has raised $37.0M in total funding. The most recent round was Series A. The last funding was announced in December 2021.

Where is Promontory Therapeutics headquartered?

Promontory Therapeutics is headquartered in New York, United States.

What does Promontory Therapeutics do?

Promontory Therapeutics is a clinical-stage pharmaceutical company focused on novel therapeutics in oncology.

What stage is Promontory Therapeutics at?

Promontory Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 14, 2021.

MLA

"Promontory Therapeutics — Funding & Investors." VCBacked, December 14, 2021, https://www.vcbacked.co/company/promontory-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2021). Promontory Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/promontory-therapeutics

Wikipedia (cite web)

{{cite web |title=Promontory Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/promontory-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 14, 2021.